Vertex Pharmaceuticals

Vertex COO Arbuckle to step down later this year
BioPharma Dive
Mon, 02/10/25 - 10:17 pm
Vertex Pharmaceuticals
Pharma COOs
Stuart Arbuckle
Charlie Wagner
Vertex's Revenue Surges but EPS Slips
Motley Fool
Mon, 02/10/25 - 10:13 pm
Vertex Pharmaceuticals
earnings
Vertex’s non-opioid pain drug gets FDA approval in milestone for company and research
BioPharma Dive
Thu, 01/30/25 - 11:36 pm
Vertex Pharmaceuticals
non-opioid pain treatments
FDA
Journavx
A long-awaited alternative to opioids is on the FDA doorstep. Can Vertex seal the deal?
Pharma Voice
Wed, 01/29/25 - 11:15 am
Vertex Pharmaceuticals
non-opioid pain treatments
suzetrigine
Vertex pays Orna $65M to work on next-gen gene therapies for blood disorders
Fierce Biotech
Tue, 01/7/25 - 10:28 am
Vertex Pharmaceuticals
Orna Therapeutics
ReNAgade Therapeutics
gene therapy
sickle cell disease
transfusion-dependent beta thalassemia
5 FDA decisions to watch in the first quarter of 2025
BioPharma Dive
Mon, 01/6/25 - 06:54 pm
FDA
Vertex Pharmaceuticals
non-opioid pain treatments
suzetrigine
GSK
vaccines
MenABCWY
meningitis
Alnylam
vutrisiran
transthyretin amyloid cardiomyopathy
Soleno
diazoxide choline
Prader Willi syndrome
Sanofi
hemophilia
fitusiran
FDA approves drugs from Vertex, Novo, Bristol Myers to wrap 2024
BioPharma Dive
Thu, 01/2/25 - 11:35 am
FDA
Vertex Pharmaceuticals
Novo Nordisk
Bristol Myers Squibb
Alyftrek
cystic fibrosis
Alhemo
hemophilia
Opdivo Qvantiq
solid tumors
Vertex's pain trial hits endpoint but sinks stock as placebo comparison spooks investors
Fierce Biotech
Thu, 12/19/24 - 10:22 am
Vertex Pharmaceuticals
suzetrigine
painkillers
non-opioid pain treatments
ICER finds Vertex's non-opioid pain drug 'slightly' cost-saving, with fewer addiction risks
First Word Pharma
Mon, 12/9/24 - 08:58 pm
Vertex Pharmaceuticals
VX-548
ICER
non-opioid pain treatments
Gene therapy uptake in sickle cell stays slow, despite patient interest
BioPharma Dive
Mon, 12/9/24 - 10:37 am
gene therapy
sickle cell disease
patients
Casgevy
Lyfgenia
Bluebird Bio
Vertex Pharmaceuticals
Vertex Pharma lifts annual revenue forecast on cystic fibrosis treatments strength
Yahoo/Reuters
Mon, 11/4/24 - 06:58 pm
Vertex Pharmaceuticals
earnings
cystic fibrosis
In pain R&D, Vertex withstood tough times to bring non-opioid suzetrigine to cusp of FDA approval
Fierce Biotech
Mon, 10/28/24 - 10:20 am
Vertex Pharmaceuticals
R&D
non-opioid pain treatments
suzetrigine
Editas cashes in on portion of Vertex gene editing licensing agreement for $57M
Fierce Biotech
Fri, 10/4/24 - 09:24 am
Editas Medicine
Cas9
patents
Vertex Pharmaceuticals
gene editing
5 FDA decisions to watch in the fourth quarter
BioPharma Dive
Wed, 10/2/24 - 11:24 am
FDA
Bridge Bio
acoramidis
AstraZeneca
Daiichi Sankyo
Dato-DXd
Vertex Pharmaceuticals
Vanza Triple
PTC Therapeutics
Upstaza
Bristol Myers Squibb
Opdivo
Vertex taps Lonza to help produce global supply of cutting-edge CRISPR therapy Casgevy
Fierce Pharma
Tue, 09/24/24 - 09:51 pm
Vertex Pharmaceuticals
CRISPR
gene editing
Lonza
Casgevy
Is anyone taking the world’s priciest drugs?
Pharma Voice
Fri, 08/30/24 - 11:28 am
drug prices
gene therapy
CRISPR Therapeutics
Vertex Pharmaceuticals
Sarepta Therapeutics
Bluebird stock plummets 18% with slow uptake of sickle cell disease gene therapy Lyfgenia
Fierce Pharma
Wed, 08/14/24 - 10:31 pm
Bluebird Bio
sickle cell disease
Vertex Pharmaceuticals
Lyfgenia
Casgevy
Vertex lifts sales guidance as launch of gene therapy Casgevy picks up steam
Fierce Pharma
Fri, 08/2/24 - 11:52 am
Vertex Pharmaceuticals
gene therapy
Casgvey
earnings
Vertex gets January 30 decision date for non-opioid pain med suzetrigine
Businesswire
Tue, 07/30/24 - 06:40 pm
Vertex Pharmaceuticals
suzetrigine
non-opioid pain treatments
FDA
Sionna revives AbbVie’s cystic fibrosis drugs, eyeing a shot at Vertex
BioPharma Dive
Tue, 07/16/24 - 12:06 pm
Sionna Therapeutics
cystic fibrosis
AbbVie
Vertex Pharmaceuticals

Pages